|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS11518 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 ICC=1:100-500 IF=1:50-200 |
| CAS編號(hào) | |
| 抗體名 | Anti-TRPM7 |
| 克隆性 | |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human TRPM7 |
產(chǎn)品訂購(gòu)信息：
英文名稱 Anti-TRPM7
中文名稱 瞬時(shí)受體電位離子通道蛋白7抗體（M亞家族）規(guī)格
別 名 CHAK 1; CHAK; CHAK1; Channel kinase 1; Channel-kinase 1; FLJ20117; FLJ25718; homolog of mouse transient receptor potential-phospholipase C-interacting kinase; Long transient receptor potential channel 7; LTRPC 7; LTRPC ion channel family member 7; LTrpC-7; LTRPC7; transient receptor potential cation channel subfamily M member 7; TRP PLIK; TRP-PLIK; TRPM 7; TRPM7; TRPM7_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 通道蛋白
蛋白分子量 predicted molecular weight: 180, 205kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human TRPM7
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
瞬時(shí)受體電位離子通道蛋白7抗體（M亞家族）規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 ICC=1:100-500 IF=1:50-200
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The protein encoded by this gene is both an ion channel and a serine/threonine protein kinase. The kinase activity is essential for the ion channel function, which serves to increase intracellular calcium levels and to help regulate magnesium ion homeostasis. Defects in this gene are a cause of amyotrophic lateral sclerosis-parkinsonism/dementia complex of Guam.[provided by RefSeq, May 2010].
Function : Essential ion channel and serine/threonine-protein kinase. Divalent cation channel permeable to calcium and magnesium. Has a central role in magnesium ion homeostasis and in the regulation of anoxic neuronal cell death. The kinase activity is essential for the channel function. May be involved in a fundamental process that adjusts plasma membrane divalent cation fluxes according to the metabolic state of the cell. Phosphorylates annexin A1 (ANXA1).
Subunit : Homodimer. Interacts with PLCB1. Forms heterodimers with TRPM6.
Subcellular Location : Membrane; Multi-pass membrane protein
Post-translational modifications : Autophosphorylated (By similarity).
DISEASE : Defects in TRPM7 are a cause of susceptibility to amyotrophic lateral sclerosis-parkinsonism/dementia complex type 1 (ALS-PDC1) [MIM:105500]; also called amyotrophic lateral sclerosis-parkinsonism/dementia complex of Guam or Guam disease. Amyotrophic lateral sclerosis-parkinsonism/dementia complex type 1 is a neurodegenerative disorder characterized by chronic, progressive and uniformly fatal amyotrophic lateral sclerosis and parkinsonism-dementia. Both diseases are known to occur in the same kindred, the same sibship and even the same individual.
Similarity : In the C-terminal section; belongs to the protein kinase superfamily. Alpha-type protein kinase family. ALPK subfamily.
In the N-terminal section; belongs to the transient receptor (TC 1.A.4) family. LTrpC subfamily. TRPM7 sub-subfamily.
Contains 1 alpha-type protein kinase domain.
Database links :
Entrez Gene: 54822 Human
Entrez Gene: 58800 Mouse
Entrez Gene: 679906 Rat
Omim: 605692 Human
SwissProt: Q96QT4 Human
SwissProt: Q923J1 Mouse
SwissProt: Q925B3 Rat
Unigene: 512894 Human
Unigene: 244705 Mouse
Unigene: 86991 Rat
Anti-TSH/FITC 熒光素標(biāo)記促甲狀腺素抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Tranthyretin 甲狀腺素運(yùn)載蛋白(抗原)Multi-class antibodies規(guī)格： 0.5mg
包含氧化還原酶的WW域抗體 Anti-WWOX 0.1ml
STARD5 英文名稱： 促黃體激素誘導(dǎo)蛋白5抗體 0.2ml
EphB6 英文名稱： 酪酸蛋白激酶受體B6抗體 0.1ml
Rhesus antibody Rh phospho-IKK beta(Ser476) 磷酸化KB抑制蛋白激酶β抗體 規(guī)格 0.1ml
Tranthyretin 甲狀腺素運(yùn)載蛋白(抗原)Multi-class antibodies規(guī)格： 0.5mg
Anti-Os05g/0477200 protein /FITC 熒光素標(biāo)記抗水稻白葉枯病菌Os05g0477200蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Mouse Anti-goat IgG/HRP 辣根過氧化物酶標(biāo)小鼠抗羊IgGMulti-class antibodies規(guī)格： 0.1ml
毒蕈堿型乙酰膽堿受體M3抗體 Anti-ChRM3 0.1ml
Mouse Anti-Rabbit IgM/PE-Cy5.5 PE-Cy5.5標(biāo)記的小鼠抗兔IgM 0.1ml
F1 operon positive regulatory protein(NT) 英文名稱： 肺耶爾森氏菌F1莢膜蛋白抗體(N端) 0.2ml
Rhesus antibody Rh PKA R2/PKA IIα 蛋白激酶A受體2α亞基抗體 規(guī)格 0.2ml
Mouse Anti-goat IgG/HRP 辣根過氧化物酶標(biāo)小鼠抗羊IgGMulti-class antibodies規(guī)格： 0.1ml
LDL-R(Low-density lipoprotein receptor precursor) 受體(抗原)Multi-class antibodies規(guī)格： 0.5mg
Anti-CD25/IL-2RA 白介素2受體a鏈抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh PAK6 P21蛋白激活的蛋白激酶6抗體 規(guī)格 0.1ml
EPOR Kit Human 人 EPOR ELISA配對(duì)抗體 ELISA
TTC21B 英文名稱： 四聚體多肽蛋白21B抗體 0.2ml
CD24 英文名稱： CD24抗體 0.1ml
Anti-CD25/IL-2RA 白介素2受體a鏈抗體Multi-class antibodies規(guī)格： 0.1ml
TNFSF12 Protein Cynomolgus 重組食蟹猴 / 人 TNFSF12 蛋白 (Fc 標(biāo)簽)
CW-2 人細(xì)胞
BCAM Others Mouse 小鼠 BCAM 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
HT-29人細(xì)胞 HT-29 human colon cancer cells McCoy's 5a+10%FBS
人T轉(zhuǎn)基因細(xì)胞;Jurkat D,E
人虹狀體上皮細(xì)胞 (HIPEpiC)( 5×105 ) HUM, 正常人主動(dòng)脈平滑肌細(xì)胞 Human
CL-0440SK-MEL-1(人皮膚細(xì)胞)5×106cells/瓶×2
TNFSF11 Others Human 人 RANKL / OPGL / TNFSF11 / CD254 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人上皮細(xì)胞RNAHBEpiC miRNA5 μg
BIU-87細(xì)胞，人細(xì)胞 穩(wěn)定轉(zhuǎn)染了neor和LIF基因的STO細(xì)胞株,SNL細(xì)胞 CSC, 小鼠心肌細(xì)胞
M1(小鼠細(xì)胞) 5×106cells/瓶×2
NHEK adult single donor Pellet 正常人類表皮角質(zhì)細(xì)胞團(tuán)塊(捐獻(xiàn)者) > 1 mio.cells 小鼠腎小管上皮細(xì)胞MREpiC
瞬時(shí)受體電位離子通道蛋白7抗體（M亞家族）規(guī)格 TNFSF12 Protein Cynomolgus 重組食蟹猴 / 人 TNFSF12 蛋白 (Fc 標(biāo)簽)
CW-2 人細(xì)胞
BCAM Others Mouse 小鼠 BCAM 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
HT-29人細(xì)胞 HT-29 human colon cancer cells McCoy's 5a+10%FBS
人T轉(zhuǎn)基因細(xì)胞;Jurkat D,E
人虹狀體上皮細(xì)胞 (HIPEpiC)( 5×105 ) HUM, 正常人主動(dòng)脈平滑肌細(xì)胞 Human
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 瞬時(shí)受體電位離子通道蛋白7抗體（M亞家族）規(guī)格 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件；
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及*基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定：
1）瞬時(shí)受體電位離子通道蛋白7抗體（M亞家族）規(guī)格 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
|
|
|
|
|
